Wake Network, Inc. Subsidiary MagicBio Research Inc. Receives a Health Canada Exemption for Research and Development on Psilocybin and Psilocin Biosynthesis
Ryan Allway August 18th, 2021 Psychedelics TORONTO, Aug. 18, 2021 /CNW/ – Wake Network, Inc. (“Wake” or the “Company“), a global leader in naturally-derived psilocybin production and the developer of genomics-based integration therapies, is pleased to announce that MagicBio Research Inc. (“MagicBio“), a wholly-owned subsidiary of Wake, has received an exemption from... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )